DOCSLIB.ORG

The Toxicology of Glycol Ethers and Its Relevance to Man (Fourth Edition) Volume I

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

The Toxicology of Glycol Ethers and its Relevance to Man (Fourth Edition) Volume I Technical Report No. 95 ISSN-0773-8072-95 Brussels, February 2005 The Toxicology of Glycol Ethers and its Relevance to Man ECETOC TECHNICAL REPORT No. 95 © Copyright – ECETOC AISBL European Centre for Ecotoxicology and Toxicology of Chemicals 4 Avenue E. Van Nieuwenhuyse (Bte 6), B-1160 Brussels, Belgium. All rights reserved. No part of this publication may be reproduced, copied, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise without the prior written permission of the copyright holder. Applications to reproduce, store, copy or translate should be made to the Secretary General. ECETOC welcomes such applications. Reference to the document, its title and summary may be copied or abstracted in data retrieval systems without subsequent reference. The content of this document has been prepared and reviewed by experts on behalf of ECETOC with all possible care and from the available scientific information. It is provided for information only. ECETOC cannot accept any responsibility or liability and does not provide a warranty for any use or interpretation of the material contained in the publication. ECETOC TR No. 95 The Toxicology of Glycol Ethers and its Relevance to Man The Toxicology of Glycol Ethers and its Relevance to Man CONTENTS - VOLUMES I AND II EXECUTIVE SUMMARY 1 SUMMARY AND CONCLUSIONS 3 Recommendations for further work 13 1. INTRODUCTION 14 1.1 Conversion factors and physico-chemical properties 14 1.2 Production and use 14 1.2.1 Manufacture of ethylene-series glycol ethers 14 1.2.2 Manufacture of propylene-series glycol ethers 15 1.2.3 Uses 15 2. TOXICOLOGICAL OVERVIEW 17 2.1 Acute toxicity 17 2.2 Irritation and sensitisation 18 2.3 Repeated-dose toxicity 19 2.3.1 Effects on the haematopoietic system and the peripheral blood 19 2.3.2 Testes 21 2.3.3 Kidney 22 2.3.4 Liver 22 2.3.5 Lymphatic tissue and immunotoxicity 23 2.3.6 Neurological effects 24 2.4 Genotoxicity and cell transformation 24 2.4.1 Evaluation 25 2.5 Chronic toxicity and carcinogenicity 25 2.5.1 Evaluation 27 2.6 Reproductive and edevelopmental toxicity 27 2.6.1 Evaluation 28 2.7 Absorption, distribution, metabolism and elimination 28 2.7.1 Absorption and distribution 28 2.7.2 Metabolism and elimination 29 2.7.3 Summary and conclusions 34 2.8 Cardiac sensitisation 35 2.9 Neurotoxicity 35 3. HUMAN EXPOSURE AND HEALTH EFFECTS 37 3.1 Human exposure 37 3.1.1 Human volunteer studies 37 3.1.2 Consumer exposure 41 3.1.3 Occupational exposure 42 ECETOC TR No. 95 The Toxicology of Glycol Ethers and its Relevance to Man 3.1.4 Measurement methods 56 3.2 Health effects 59 3.2.1 Haematological effects 60 3.2.2 Behavioural and neurological effects 62 3.2.3 Reproductive effects 63 3.2.4 Other effects, including poisoning 67 3.3 Occupational exposure limit values 72 4. SUBSTANCE PROFILES (VOLUME II/CD) 73 4.1 Substance profile: EGME 4.2 Substance profile: EGMEA 4.3 Substance profile: EGDME 4.4 Substance profile: DEGME 4.5 Substance profile: DEGDME 4.6 Substance profile: TEGME 4.7 Substance profile: TEGDME 4.8 Substance profile: MAA 4.9 Substance profile: EGEE 4.10 Substance profile: EGEEA 4.11 Substance profile: EGDEE 4.12 Substance profile: DEGEE 4.13 Substance profile: DEGEEA 4.14 Substance profile: DEGDEE 4.15 Substance profile: TEGEE 4.16 Substance profile: EGiPE 4.17 Substance profile: EGiPEA 4.18 Substance profile: EGnPE 4.19 Substance profile: EGnPEA 4.20 Substance profile: EGPhE 4.21 Substance profile: EGBE 4.22 Substance profile: EGBEA 4.23 Substance profile: DEGBE 4.24 Substance profile: DEGBEA 4.25 Substance profile: TEGBE 4.26 Substance profile: EGHE 4.27 Substance profile: DEGHE 4.28 Substance profile: 2PG1ME 4.29 Substance profile: 2PG1MEA 4.30 Substance profile: 1PG2ME 4.31 Substance profile: 1PG2MEA 4.32 Substance profile: DPGME 4.33 Substance profile: TPGME 4.34 Substance profile: 2PG1EE 4.35 Substance profile: 2PG1EEA 4.36 Substance profile: DPGEE 4.37 Substance profile: PGPE 4.38 Substance profile: DPGPE ECETOC TR No. 95 The Toxicology of Glycol Ethers and its Relevance to Man 4.39 Substance profile: 2PG1PhE 4.40 Substance profile: 2PG1BE 4.41 Substance profile: DPGBE 4.42 Substance profile: TPGBE 4.43 Substance profile: PGTBE 4.44 Substance profile: DPGTBE 5. BIBLIOGRAPHY 74 5.1 Databases consulted 74 5.2 References quoted 74 5.3 References not quoted 159 APPENDIX A: SPECIAL ABBREVIATIONS 170 APPENDIX B: CONVERSION FACTORS FOR VAPOUR CONCENTRATIONS IN AIR 173 APPENDIX C: OCCUPATIONAL EXPOSURE LIMIT VALUES 174 MEMBERS OF THE TASK FORCE 194 MEMBERS OF THE SCIENTIFIC COMMITTEE 196 ECETOC TR No. 95 The Toxicology of Glycol Ethers and its Relevance to Man EXECUTIVE SUMMARY This report provides an update of an earlier ECETOC review a of a number of important ethylene and propylene glycol mono-ethers and di-ethers (glymes). It includes substantial new information concerning the human health consequences of exposure to this class of chemicals. The report presents toxicity data profiles for each individual compound. Glycol mono-ethers are liquids that combine the solubility characteristics of ethers and alcohols since both functional groups are present. As a result, they are widely used in solvent applications, including formulations such as paints, inks and cleaning fluids. Non-solvent applications include uses as anti-icing agents in jet fuel, hydraulic system fluids and as chemical intermediates. The hazard assessment of several glycol ethers can be based on short-term exposure studies because long-term exposure have not lead to more severe or different systemic effects. Glycol ethers have the potential to penetrate the skin (as a liquid or vapour) and this, therefore, represents a potentially significant route of exposure. The majority of glycol ethers are of low acute toxicity; the main effect seen in laboratory animals at high doses is narcosis, typical of many solvents. Some glycol ethers are eye irritants. Overall, numerous studies with glycol ethers show that they do not exhibit genotoxic activity. The results of carcinogenicity studies with glycol ethers are consistent with this lack of genotoxic activity. The systemic toxicity of the ethylene-based glycol ethers is mediated by their metabolism to the corresponding alkoxyacetic acids. Methyl- and ethyl-substituted ethylene glycol ethers can cause bone marrow depression, testicular atrophy, developmental toxicity, and immunotoxicity in animals. It should be noted that methyl- and ethyl-ethers of ethylene glycol are not used in consumer products in Europe. In contrast, the longer chain ethylene glycol ethers (ethylene glycol butyl ether, -propyl ether, -isopropyl ether and -phenyl ether) do not cause any of these effects. Toxicity commonly associated with the longer chain homologues involves red blood cell haemolysis (anaemia), to which humans are resistant. The alkoxyacetic acid metabolites of glycol ethers are responsible for the haemolysis. None of the ethylene-bond effects have been observed for the propylene glycol ethers (α-isomers in commercial products); they are secondary alcohols and cannot be metabolised to their corresponding alkoxypropionic acids. Propylene glycol ethers are dealkylated to propylene glycol and then oxidised. The only change observed with propylene glycol ethers is an adaptive liver response and male rat kidney toxicity, which is not considered relevant to humans. a ECETOC. 1995. The toxicology of glycol ethers and its relevance to man. Technical Report 64. European Centre for Ecotoxicology and Toxicology of Chemicals, Brussels, Belgium [ISSN-0773-8072-64] ECETOC TR No. 95 1 The Toxicology of Glycol Ethers and its Relevance to Man Reports of a number of effects in humans have been associated with glycol ether exposure, such as anaemia, granulocytopenia and leukopenia, increased risk of abortion or reduced sperm count in painters. Many such reports relate to methyl- and ethyl-substituted glycol ethers and are confounded by simultaneous exposures to other chemicals as well as limited information on exposure levels, which do not allow firm conclusions to be made concerning the contribution of glycol ethers to the observed effects. The toxicological findings reported to date indicate that, except for haemolytic anaemia and the liver and kidney effects in long-term studies, the effects seen in animals are also relevant to humans. ECETOC TR No. 95 2 The Toxicology of Glycol Ethers and its Relevance to Man SUMMARY AND CONCLUSIONS Glycol mono-ethers are liquids that combine the solubility characteristics of ethers and alcohols since both functional groups are present in the molecule. They are therefore widely used in solvent applications, including formulations such as paints, inks and cleaning fluids. Non-solvent applications include uses as anti-icing agents in jet fuel, hydraulic system fluids and as chemical intermediates. The majority of glycol ethers are of low acute toxicity. Clinical signs of acute intoxication in animals are consistent with non-specific depression of the central nervous system, which is typical of many solvents. Lethargy and haemoglobinuria have been observed in glycol ethers that produced haemolysis in rodents. Although some glycol ethers are irritant to the eye, most are not, and none are appreciably irritant to the skin on acute exposure. As with other solvents, prolonged or repeated skin exposure may lead to a severe skin irritation. It is recognised that the glycol ether class lacks specific determinants for either genotoxicity or carcinogenicity. Negative results obtained in conventional genotoxicity assays, both in vivo and in vitro, confirm the lack of genotoxic activity for this class of solvents. Some glycol ethers have been tested in life-time studies in rats and mice, including ethylene glycol ethyl ether, ethylene glycol n-butyl ether, diethylene glycol ethyl ether, 2-propylene glycol 1-methyl ether and propylene glycol tert-butyl ether.
Recommended publications
  • 36Th ITC Report

    36Th ITC Report

    Thursday August 17, 1995 Part V Environmental Protection Agency Thirty-Sixth Report of the TSCA Interagency Testing Committee to the Administrator; Receipt of Report, Request for Comments, Solicitation of Use and Exposure Data; Notice federal register 42981 42982 Federal Register / Vol. 60, No. 159 / Thursday, August 17, 1995 / Notices ENVIRONMENTAL PROTECTION comments and data in electronic form ``OPPTS±41043'' (including comments AGENCY must be identified by the docket number and data submitted electronically as OPPT±41043. No CBI should be described below). A public version of [OPPTS±41043; FRL±4965±6] submitted through e-mail. Electronic this record, including printed, paper Thirty-Sixth Report of the TSCA comments on this notice may be filed versions of electronic comments, which Interagency Testing Committee to the online at many Federal Depository does not include any information Administrator; Receipt of Report, Libraries. Additional information on claimed as confidential business Request for Comments, Solicitation of electronic submissions can be found in information (CBI), is available for Use and Exposure Data Unit III of this document. inspection from 12 noon to 4 p.m., FOR FURTHER INFORMATION CONTACT: Monday through Friday, excluding legal AGENCY: Environmental Protection Susan B. Hazen, Director, holidays. The public record is located in Agency (EPA). Environmental Assistance Division the TSCA Nonconfidential Information ACTION: Notice. (7408), Office of Pollution Prevention Center, Rm. NE-B607, 401 M St., SW., and Toxics, Environmental Protection Washington, DC 20460. SUMMARY: The TSCA Interagency Agency, 401 M Street, SW., Rm. E± Electronic comments can be sent Testing Committee (ITC), established 543B, Washington, DC 20460, (202) directly to EPA at: under section 4(e) of the Toxic 554±1404, TDD (202) 554±0551, [email protected] Substances Control Act (TSCA), Internet: TSCA- transmitted its Thirty-Sixth Report to [email protected].
  • Dipropylene Glycol Ethyl Ether (DPGEE) [Ethyl DIPROXITOL] Product Stewardship Summary December 2017

    Dipropylene Glycol Ethyl Ether (DPGEE) [Ethyl DIPROXITOL] Product Stewardship Summary December 2017

    DiPropylene Glycol Ethyl Ether (DPGEE) [Ethyl DIPROXITOL] Product Stewardship Summary December 2017 DiPropylene Glycol Ethyl Ether (DPGEE) [Ethyl DIPROXITOL] Product Stewardship Summary (CAS number 30025-38-8) Chemical Formula for DPGEE C8H18 O3 What is DPGEE? DPGEE is a glycol ether based on Propylene oxide and ethanol. It is a speciality solvent having a bi- functional nature (ether-alcohol). It is a clear liquid with an ethereal odour. The Shell Chemicals range of Propylene oxide-based glycol ethers are sold under the trade name PROXITOL. How is DPGEE Used? It is used as an intermediate and in formulations in industrial, professional or consumer applications, mainly in surface coatings and printing inks and paints, cleaners, agrochemical or de-icing/anti-icing formulations. Health, Safety and Environmental Considerations DPGEE is flammable liquids with a flashpoint of 180 0F/82 0C. DPGEE is an isomer mix, of which the main component is 1-Ethoxypropanol-2 (typically 98% or more). Shell PROXITOLs are not classified as carcinogens or mutagens, are not expected to cause cancer in humans, nor do they impair fertility or damage the developing foetus. DPGEE is of low toxicity towards aquatic organisms. They are completely miscible with water, biodegradable and not expected to bio-accumulate. Storing and Transporting DPGEE DPGEE is transported by tank truck, rail car and vessel, primarily in bulk quantities, but also as packed product. Due to its flammability, they are classified as hazardous for transport under transport regulations. Glycol Ethers should be stored at ambient temperatures away from sources of ignition and substances with oxidising or corrosive properties.
  • R Graphics Output

    R Graphics Output

    Dexamethasone sodium phosphate ( 0.339 ) Melengestrol acetate ( 0.282 ) 17beta−Trenbolone ( 0.252 ) 17alpha−Estradiol ( 0.24 ) 17alpha−Hydroxyprogesterone ( 0.238 ) Triamcinolone ( 0.233 ) Zearalenone ( 0.216 ) CP−634384 ( 0.21 ) 17alpha−Ethinylestradiol ( 0.203 ) Raloxifene hydrochloride ( 0.203 ) Volinanserin ( 0.2 ) Tiratricol ( 0.197 ) trans−Retinoic acid ( 0.192 ) Chlorpromazine hydrochloride ( 0.191 ) PharmaGSID_47315 ( 0.185 ) Apigenin ( 0.183 ) Diethylstilbestrol ( 0.178 ) 4−Dodecylphenol ( 0.161 ) 2,2',6,6'−Tetrachlorobisphenol A ( 0.156 ) o,p'−DDD ( 0.155 ) Progesterone ( 0.152 ) 4−Hydroxytamoxifen ( 0.151 ) SSR150106 ( 0.149 ) Equilin ( 0.3 ) 3,5,3'−Triiodothyronine ( 0.256 ) 17−Methyltestosterone ( 0.242 ) 17beta−Estradiol ( 0.24 ) 5alpha−Dihydrotestosterone ( 0.235 ) Mifepristone ( 0.218 ) Norethindrone ( 0.214 ) Spironolactone ( 0.204 ) Farglitazar ( 0.203 ) Testosterone propionate ( 0.202 ) meso−Hexestrol ( 0.199 ) Mestranol ( 0.196 ) Estriol ( 0.191 ) 2,2',4,4'−Tetrahydroxybenzophenone ( 0.185 ) 3,3,5,5−Tetraiodothyroacetic acid ( 0.183 ) Norgestrel ( 0.181 ) Cyproterone acetate ( 0.164 ) GSK232420A ( 0.161 ) N−Dodecanoyl−N−methylglycine ( 0.155 ) Pentachloroanisole ( 0.154 ) HPTE ( 0.151 ) Biochanin A ( 0.15 ) Dehydroepiandrosterone ( 0.149 ) PharmaCode_333941 ( 0.148 ) Prednisone ( 0.146 ) Nordihydroguaiaretic acid ( 0.145 ) p,p'−DDD ( 0.144 ) Diphenhydramine hydrochloride ( 0.142 ) Forskolin ( 0.141 ) Perfluorooctanoic acid ( 0.14 ) Oleyl sarcosine ( 0.139 ) Cyclohexylphenylketone ( 0.138 ) Pirinixic acid ( 0.137 )
  • Pesticides and Toxic Substances

    Pesticides and Toxic Substances

    UNITED STATES ENVIRONMENTAL PROTECTION AGENCY WASHINGTON, D.C. 20460 OFFICE OF PREVENTION, PESTICIDES AND TOXIC SUBSTANCES CERTIFIED MAIL Dear Registrant: This is to inform you that the Environmental Protection Agency (hereafter referred to as EPA or the Agency) has completed its review of the available data for the antimicrobials propylene glycol and dipropylene glycol. The Reregistration Eligibility Decision (RED) was approved in the form of a decision memorandum which summarized the regulatory decision for propylene glycol and dipropylene glycol on September 30, 2004. Based on its review, EPA is now publishing its Reregistration Eligibility Decision (RED) for propylene glycol and dipropylene glycol and its associated human health and environmental risks. A Notice of Availability will be published in the Federal Register announcing the publication of the RED. The RED and supporting documents for propylene glycol and dipropylene glycol will be available to the public in EPA’s Pesticide Docket EPA-HQ-OPP-2006-0831 at: www.regulations.gov. Please note that the attached RED document pertains only to propylene glycol and dipropylene glycol. This RED presents the Agency’s conclusions on the dietary, drinking water, occupational and ecological risks posed by exposure to propylene glycol or dipropylene glycol alone. This document also contains product-specific data that the Agency intends to require in Data Call-Ins (DCIs). Note that DCIs, with all pertinent instructions, will be sent to registrants at a later date. Currently, there are no generic data requirements. Additionally, for product- specific DCIs, the first set of required responses will be due 90 days from the receipt of the DCI letter.
  • Formulating Water-Based Systems Y,Ith Propylene-Oxide­ Based Glycol Ethers

    Formulating Water-Based Systems Y,Ith Propylene-Oxide­ Based Glycol Ethers

    Formulating Water-Based Systems y,ith Propylene-Oxide­ Based Glycol Ethers Carmen l. Rodriguez and Julia Weathers-lyondell Chemical Company· Bernadette Corujo-Engineered Polymer Solutions Patricia Peterson-Avecia To camply with environmental regulations, formulators have reformulated to water-based systems using non-hazardous air pollutants (non-HAP) cosolvents and developed new resin technology. In fully formulated water-based systems, however, changing the solvent system to meet environmental regulations has wide ranging effects on viscosity, surface defects, film shrinkage, adhesion, and durability. Formulators often adjust paint viscosity by balancing the levels of cosolvents, surfactants, and rheology modifiers. Reformulating with non-HAPs solvents such as propylene oxide-based glycol ethers (PG-glycol ethers) helps reduce volah1e organic content WOC) to meet environmental compliance and eliminates HAPs reporting requirements. When replacing ethylene oxide-based glycol ethers (EG-glycol ethers) with their PG-glycol ethers, reformulation seems simple enough, particularly if evaporation rates and solubility parameters are matched. A drop-in replacement, however, requires optimization. This study compares the use ofPG-glycol ethers in four architectural latex paints and assesses their effects on rheology, drying, and some key performance attributes. INTRODUCTION ing a suitable coalescent solvent for a solvent in the filmis stronglydependent waterborne coating.1 However, chang­ on the end use. The principal positive The primary reason for reformulating a ing the solvent package in a coating for­ effect of solvent entrapment is the in­ solventsystemis to meet environmental mulation may also necessitate optimiza­ creased fleXIbility of the cured coating compliance in volatile organic content tion of the other paint components. and possibly superior cure.
  • Mathematical Formulation and Parametric Analysis of In

    Mathematical Formulation and Parametric Analysis of In

    www.nature.com/scientificreports OPEN Mathematical formulation and parametric analysis of in vitro cell models in microfuidic devices: application to diferent stages of glioblastoma evolution Jacobo Ayensa‑Jiménez1,2, Marina Pérez‑Aliacar1,2, Teodora Randelovic1,2, Sara Oliván1,2, Luis Fernández1,2,3, José Antonio Sanz‑Herrera4, Ignacio Ochoa1,2,3, Mohamed H. Doweidar1,2,3 & Manuel Doblaré1,2,3* In silico models and computer simulation are invaluable tools to better understand complex biological processes such as cancer evolution. However, the complexity of the biological environment, with many cell mechanisms in response to changing physical and chemical external stimuli, makes the associated mathematical models highly non‑linear and multiparametric. One of the main problems of these models is the determination of the parameters’ values, which are usually ftted for specifc conditions, making the conclusions drawn difcult to generalise. We analyse here an important biological problem: the evolution of hypoxia‑driven migratory structures in Glioblastoma Multiforme (GBM), the most aggressive and lethal primary brain tumour. We establish a mathematical model considering the interaction of the tumour cells with oxygen concentration in what is called the go or grow paradigm. We reproduce in this work three diferent experiments, showing the main GBM structures (pseudopalisade and necrotic core formation), only changing the initial and boundary conditions. We prove that it is possible to obtain versatile mathematical tools which, together with a sound parametric analysis, allow to explain complex biological phenomena. We show the utility of this hybrid “biomimetic in vitro‑in silico” platform to help to elucidate the mechanisms involved in cancer processes, to better understand the role of the diferent phenomena, to test new scientifc hypotheses and to design new data‑driven experiments.
  • 2-Ethoxyethanol

    2-Ethoxyethanol

    2-Ethoxyethanol Product Number E 2632 Store at Room Temperature Product Description Precautions and Disclaimer Molecular Formula: C4H10O2 For Laboratory Use Only. Not for drug, household or Molecular Weight: 90.12 other uses. CAS Number: 110-80-5 Boiling point: 135 °C Preparation Instructions Melting point: -70 °C Ethylene glycol monoethyl ether is miscible with water Density: 0.931 g/ml and organic solvents. Synonyms: Ethyl glycol, Cellosolve, ethylcellosolve, ethylene glycol monoethyl ether, 2EE References 1. The Merck Index, 13th ed., Entry# 3786. 2-Ethoxyethanol is used as a component or solvent for 2. Aasmoe, L., and Aarbakke, J., Sex-dependent nitrocellulose, a wide variety of dyes, inks, cleaning induction of alcohol dehydrogenase activity in rats. agents, resins, paints, and varnishes. It is used for Biochem. Pharmacol., 57(9), 1067-1072 (1999). increasing the stability of emulsions.1 3. Hoflack, J. C., et al., Glycol ethers induce death and necrosis in human leukemia cells. Biochem. The teratogenic effects of 2EE are due to the Cell Biol., 75(4), 415-425 (1997). alkoxyacetic acid metabolites formed via the alcohol 4. Zhao, S. P., et al., Effect of simvastatin on the dehydrogenase pathway.2 The effect of 2EE on apparent size of LDL particles in patients with type human leukemic cells lines HL-60, MOLT3, and K562 IIB hyperlipoproteinemia. Clin. Chim. Acta, has been described.3 203(2-3), 109-117 (1991). 2-Ethoxyethanol has been used as a destaining Coomassie is a registered trademark of Imperial solution for lipoproteins on polyacrylamide gels stained Chemical Industries PLC. with Sudan Black B. Gels were destained with a GRS/ALF/RXR 10/03 solution of 50% ethylene glycol monoethyl ether in water for 2 hours.
  • Reticulocytosis in Screen-Printing Workers Exposed to 2

    Reticulocytosis in Screen-Printing Workers Exposed to 2

    Song et al. Annals of Occupational and Environmental Medicine (2017) 29:54 DOI 10.1186/s40557-017-0210-z RESEARCHARTICLE Open Access Reticulocytosis in screen-printing workers exposed to 2-butoxyethanol and 2- ethoxyethanol Seng-Ho Song, Seong-Kyu Kang*, Won-Jun Choi, Kyeong Min Kwak, Dong-Hoon Lee, Dyuk-Yoon Kang and Sang-Ha Lee Abstract Background: Studies on the hematologic toxicity of ethylene glycol ethers in humans are limited. Therefore, the aim of this study was to examine the association between exposure to solvents (containing 2-butoxyethanol and 2-ethoxyethanol) and hematological effects. Methods: Thirty-four screen-printing workers who were exposed to 2-butoxyethanol and 2-ethoxyethanol and 37 non- exposed clerical workers were selected using data from the health care facilities that provided regular health screening services. Student’s t-tests and Pearson’s chi-square tests were used to compare differences in hematological parameters between the exposed and the control groups. A multivariate analysis was performed using the multiple logistic regression models to adjust for other variables. Results: The chi-square test showed the reticulocyte percentages and corrected reticulocyte counts to be significantly higher in the exposed group. The t-tests showed a significant increase in white blood cell counts, reticulocyte percentages, and corrected reticulocyte count (i.e., reticulocyte index) in the exposed group, with p-values of 0.002, 0.004, and 0.002, respectively. Multivariate analysis showed the odds ratio for the corrected reticulocyte counts to be 16.30 for the exposed group, when compared with that of the control group. Conclusions: Exposure to 2-butoxyethanol and 2-ethoxyethanol was significantly associated with reticulocytosis, necessitating the implementation of preventive measures for workers prone to occupational exposure to ethylene glycol ethers.
  • Lubricants in Pharmaceutical Solid Dosage Forms

    Lubricants in Pharmaceutical Solid Dosage Forms

    Lubricants 2014, 2, 21-43; doi:10.3390/lubricants2010021 OPEN ACCESS lubricants ISSN 2075-4442 www.mdpi.com/journal/lubricants Review Lubricants in Pharmaceutical Solid Dosage Forms Jinjiang Li * and Yongmei Wu Drug Product Science & Technology, Bristol-Myers Squibb Corporation, 1 Squibb Dr., New Brunswick, NJ 08903, USA; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +1-732-227-6584; Fax: +1-732-227-3784. Received: 18 December 2013; in revised form: 21 January 2014 / Accepted: 24 January 2014 / Published: 25 February 2014 Abstract: Lubrication plays a key role in successful manufacturing of pharmaceutical solid dosage forms; lubricants are essential ingredients in robust formulations to achieve this. Although many failures in pharmaceutical manufacturing operations are caused by issues related to lubrication, in general, lubricants do not gain adequate attention in the development of pharmaceutical formulations. In this paper, the fundamental background on lubrication is introduced, in which the relationships between lubrication and friction/adhesion forces are discussed. Then, the application of lubrication in the development of pharmaceutical products and manufacturing processes is discussed with an emphasis on magnesium stearate. In particular, the effect of its hydration state (anhydrate, monohydrate, dihydrate, and trihydrate) and its powder characteristics on lubrication efficiency, as well as product and process performance is summarized. In addition, the impact of lubrication on the dynamics of compaction/compression processes and on the mechanical properties of compacts/tablets is presented. Furthermore, the online monitoring of magnesium stearate in a blending process is briefly mentioned. Finally, the chemical compatibility of active pharmaceutical ingredient (API) with magnesium stearate and its reactive impurities is reviewed with examples from the literature illustrating the various reaction mechanisms involved.
  • Alcohols & Glycols Kleinschmidt

    Alcohols & Glycols Kleinschmidt

    8/13/14 Alcohols," Glycols, &" “Cat”cols Kurt Kleinschmidt, MD Section Chief and Program Director, Medical Toxicology UT Southwestern Medical Center Dallas, Texas Alcohols and Glycols • “Iso” means branching of carbon chain • “Glycol” means 2 hydroxyl groups • Ethylene glycol Antifreeze • Propylene glycol Refrigerant • Polyalkylene glycol Refrigerant oil • Physiochemical behavior • If small hydrocarbon group, acts like water • If large hydrocarbon group, acts like the HC-group Alcohols and Glycols: Glycol Ethers • Clear, Syrupy liquid; Inoffensive odors; Low Vapor pressure; Non-flammable • Water & Organic soluble … Very Nice!...”Couplers”! • Do not bioaccumulate b/c undergo rapid hydrolysis • Rapid Dermal, inhalation, and oral absorption • Molecular Weight êèé Dermal absorption • Uses: Solvents Household cleaning products (windows) Humectant and plasticizer Semiconductor industry Brake fluid Diluent Deicers Paints and Coatings 1 8/13/14 Alcohols and Glycols: Glycol Ethers • Two groups: EG Monoalkyl Ethers base: • Ethylene glycol ethers R1OCH2CH2OR2 • Propylene glycol ethers R1=Alkyl gp; R2=H or Acetate • Ethylene Glycol Ethers • Many exist Ethylene Glycol • 2 examples……………. Methyl Ether (EGME) Ethers: R1-O-R2 Ethylene Glycol • Propylene Glycol Ethers Butyl Ether (EGBE) • Many • Example Is a 2o alcohol Propylene Glycol (On the 2nd Carbon) Monomethyl Ether Alcohols and Glycols: " Glycol Ethers Metabolism • ADH is key one: è Alkoxyacetic acids • Toxic Metabolite è Reproductive Problems Ethylene • Gap Acidosis Glycol • Minor route & Debatableè ethylene glycol Ether • Oxaluria seen after some methoxyethanol & butoxyethanol ingestions • But… Ether linkage is fairly stable Is No direct evidence to support Propylene • Its 2o –OH è ADH does NOT metabolize Glycol • CYP Metabolism è CO2 (Non-Toxic) Ethers • Replacing the ethylene glycol ethers Alcohols and Glycols " Clinical Glycol Ethers • Reproductive Not/Less • Animal studies è Reproduction Injury (Spont.
  • Substance Name(S): 2-Ethoxyethanol EC Number: 203-804-1 CAS Number: 110-80-5

    Substance Name(S): 2-Ethoxyethanol EC Number: 203-804-1 CAS Number: 110-80-5

    2-ETHOXYETHANOL SVHC SUPPORT DOCUMENT Substance Name(s): 2-Ethoxyethanol EC number: 203-804-1 CAS Number: 110-80-5 MEMBER STATE COMMITTEE SUPPORT DOCUMENT FOR IDENTIFICATION OF 2-ETHOXYETHANOL AS A SUBSTANCE OF VERY HIGH CONCERN BECAUSE OF ITS CMR PROPERTIES Adopted on 25 November 2010 2-ETHOXYETHANOL SVHC SUPPORT DOCUMENT CONTENTS 1 IDENTITY OF THE SUBSTANCE AND PHYSICAL AND CHEMICAL PROPERTIES ................ 4 1.1 NAME AND OTHER IDENTIFIERS OF THE SUBSTANCE ............................................................................. 4 1.2 COMPOSITION OF THE SUBSTANCE ........................................................................................................ 4 1.3 PHYSICO -CHEMICAL PROPERTIES .......................................................................................................... 5 2 HARMONISED CLASSIFICATION AND LABELLING...................................................................... 6 3 ENVIRONMENTAL FATE PROPERTIES............................................................................................. 8 4 HUMAN HEALTH HAZARD ASSESSMENT ........................................................................................ 8 4.1 TOXICITY FOR REPRODUCTION .............................................................................................................. 8 5 ENVIRONMENTAL HAZARD ASSESSMENT ..................................................................................... 8 6 CONCLUSIONS ON THE SVHC PROPERTIES ..................................................................................
  • Glycol Ethers Method 2554

    Glycol Ethers Method 2554

    GLYCOL ETHERS 2554 (1) CH3OCH2CHOHCH3 MW: 90.1 CAS: 107-98-2 RTECS: UB7700000 (2) CH3OC3H6OC3H6OH 148.2 34590-94-8 JM1575000 (3) CH3OCH2CH(CH3)COOCH3 132.16 108-65-6 AI8925000 METHOD: 2554 EVALUATION: PARTIAL Issue 1: 15 March 2003 OSHA : See Table I PROPERTIES: See Table I NIOSH: See Table I ACGIH: See Table I SYNONYMS: (1) propylene glycol monomethyl ether, 1-methoxy-2-propanol, 2-methoxy-1-methylethanol, propylene glycol methyl ether (2) dipropylene glycol monomethyl ether (3) propylene glycol monomethyl ether acetate, propylene glycol methyl ether acetate, 1-methoxy-2-propyl acetate SAMPLING MEASUREMENT SAMPLER: SOLID SORBENT TUBE TECHNIQUE: GAS CHROMATOGRAPHY, FID (Anasorb® 747, 140 mg/70 mg) ANALYTE: See Table I FLOW RATE: 0.1 to 0.2 L/min DESORPTION: 1 mL of methylene chloride/methanol VOL-MIN: 3 L (85:15) for 30 minutes in ultrasonic bath -MAX: 25 L (at lower flow rates) INJECTION VOLUME: 1 :L SHIPMENT: Keep cold, pack securely for shipping TEMPERATURE SAMPLE -INJECTION: 195°C STABILITY: 14 days @ 5°C for analytes 1 and 3; -DETECTOR: 240°C 7 days @ 5°C for analyte 2 -COLUMN: 90°C (1 min) to 200°C (10°C/min) BLANKS: 2 to 10 field blanks per set CARRIER GAS: Helium, 2.8 mL/min COLUMN: Capillary, fused silica, 30 m x 0.32-mm ACCURACY ID; 100% PEG-DA, Stabilwax or equivalent RANGE STUDIED: Not determined. CALIBRATION: Solutions of analytes in desorption BIAS: Not determined. solvent Ö RANGE: (1) 1.5 to 369 :g[3] OVERALL PRECISION ( rT): Not determined. (2) 3.0 to 375 :g[3] ACCURACY: Not determined (3) 1.5 to 369 :g[3] ESTIMATED LOD: (1) 0.5 :g[3] (2) 1.0 :g[3] (3) 0.5 :g[3] þ PRECISION ( r): (1) 0.013[3] (2) 0.031[3] (3) 0.016[3] APPLICABILITY: The working range for propylene glycol monomethyl ether was 0.041 to 10.0 ppm (0.154 to 36.9 mg/m3), for dipropylene glycol monomethyl ether was 0.050 to 6.19 ppm (0.305 to 37.5 mg/m3), and propylene glycol monomethyl ether acetate was 0.030 to 6.83 ppm (0.151 to 36.9 mg/m3) for a 10 L sample .